SOADOR
INDV icon

State of Alaska Department of Revenue’s Indivior Pharmaceuticals INDV Stock Holding History

State of Alaska Department of Revenue’s Portfolio INDV Stock Details INDV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.65M Sell
40,151
-21,481
-35% -$779K 0.02% 784
2026
Q1 		$1.88M Sell
61,632
-1,906
-3% -$62.9K 0.02% 739
2025
Q4 		$2.28M Buy
+63,538
New +$1.94M 0.02% 642

Other funds holding INDV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return
TSC
Two Seas Capital Rye, New York $5.05B AUM 164.99% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return

State of Alaska Department of Revenue's INDV Position: Q2 2026 in Review

State of Alaska Department of Revenue reduced its Indivior Pharmaceuticals (INDV) stake by 35% in Q2 2026, selling an estimated $779K and leaving 40,151 shares worth $1.65M. The position accounts for 0.02% of the portfolio, ranked #784.

State of Alaska Department of Revenue first reported a position in INDV in Q4 2025 and has held it in 3 quarters since. The position peaked at $2.28M in Q4 2025. 198 funds tracked by Wall St. Rank hold INDV as of Q2 2026.

  • State of Alaska Department of Revenue held 40,151 shares of Indivior Pharmaceuticals worth $1.65M as of Q2 2026.
  • State of Alaska Department of Revenue sold 21,481 Indivior Pharmaceuticals shares in Q2 2026, an estimated $779K.
  • Indivior Pharmaceuticals made up 0.02% of State of Alaska Department of Revenue's portfolio in Q2 2026, its #784 holding.
  • State of Alaska Department of Revenue first reported a position in Indivior Pharmaceuticals in Q4 2025 and has held it in 3 quarters since.
  • State of Alaska Department of Revenue's Indivior Pharmaceuticals position peaked at $2.28M in Q4 2025.
  • 198 funds tracked by Wall St. Rank held Indivior Pharmaceuticals as of Q2 2026.

Based on State of Alaska Department of Revenue's 13F filing for Q2 2026, filed 20 Jul 2026.